Results 51 to 60 of about 6,270 (121)

Gene Therapy Using Recombinant Adeno-Associated Virus for Leber Congenital Amaurosis Induced by RPE65 Mutation. [PDF]

Clin Ophthalmol
Owliaee I, Teimoori A, Shoushtari M, Shojaeian A.   +3 more
europepmc   +1 more source

Terminal glucose as a receptor for adeno-associated virus 44.9. [PDF]

J Virol
Di Pasquale G, Tehrani H, Shinder I, Afione S, Chiorini JA.   +4 more
europepmc   +1 more source

Determination of AAV Capsid Protein Ratios by Sodium Dodecyl Sulfate Capillary Electrophoresis (CE-SDS)-UV Absorption Method. [PDF]

Electrophoresis
Li Y, Sun Y, Li X, Bi H, Pei D, Fu Z, Ding Y, Pan Y, Qin X, Liang C, Wang L.   +10 more
europepmc   +1 more source

Aiming for spatial and temporal control of gene expression. [PDF]

Elife
Igor Travisano S, Lien CL.
europepmc   +1 more source

EctoShed: a novel gene delivery platform for functional analysis of adipocyte-shed proteoforms. [PDF]

BMC Res Notes
Tavanez AR, Egedal NM, Stanic N, Topel H, Kornfeld JW.   +4 more
europepmc   +1 more source

YAP Acts as a Negative Regulator of Mini Utrophin-Based Gene Therapy for Duchenne Muscular Dystrophy in Mdx Mice. [PDF]

Int J Mol Sci
Li Z, Song Y.
europepmc   +1 more source

Could AAV-vectored delivery of broadly neutralizing antibodies (bNAbs) reduce virologic failure in children diagnosed with perinatal HIV? [PDF]

Hum Vaccin Immunother
Pringle KL, Martins MA.
europepmc   +1 more source

mGem: AAV, from almost a virus to an awesome vector-or is it? [PDF]

mBio
Srivastava A.
europepmc   +1 more source

98. Characterisation of a Unique Adeno-Associated Virus Forming a New Clade within the Dependovirus Genus

Molecular Therapy, 2009
openaire   +1 more source

Steering Protein Generative Models at Test-Time for Guided AAV2 Capsid Design. [PDF]

Pac Symp Biocomput
Viggiano B, Lu WS, Zhang X, Mille-Fragoso LS, Gao XJ, Ashley E, Wong WH.   +6 more
europepmc   +1 more source